Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.63 |
| ▸ | TERT | O14746 | 3/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | PPARG | P37231 | 3/20 | 0.57 |
| ▸ | PPARD | Q03181 | 3/20 | 0.57 |
| ▸ | PPARA | Q07869 | 3/20 | 0.57 |
| ▸ | F7 | P08709 | 3/20 | 0.57 |
| ▸ | F3 | P13726 | 3/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.57 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28905639 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL28717295 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL10476863 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL5792039 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL2573674 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL10476864 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL28720703 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL2571576 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL2571577 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 | |
| SCHEMBL28717374 | 1.00 | FASN (0.63) | FASNMAPTABCC4TERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466917-B1 | METHOD FOR PREPARING (7E)- 7,9-DECADIENOATE ESTER | SHINETSU CHEMICAL CO (JP) | 2020-06-24 | — | — | EP | claimed |
| EP-1268930-B1 | Method for making a coating composition | BASF SE (DE) | 2009-09-09 | — | — | EP | claimed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-109627162-B | Process for preparing (7E) -7, 9-decanedioic acid esters | 信越化学工业株式会社 | 2022-11-15 | — | — | CN | disclosed |
| CN-114788872-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114569726-A | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-114380689-A | Haloalkenylalkoxymethyl ethers and processes for preparing terminally conjugated alkadien-1-yl acetates and alkadien-1-ols therefrom | 信越化学工业株式会社 | 2022-04-22 | — | — | CN | disclosed |
| EP-3466917-B1 | METHOD FOR PREPARING (7E)- 7,9-DECADIENOATE ESTER | SHINETSU CHEMICAL CO (JP) | 2020-06-24 | — | — | EP | disclosed |
| US-20200155575-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-20190106374-A1 | METHOD FOR PREPARING (7E)-7, 9-DECADIENOATE ESTER | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-04-11 | — | — | US | disclosed |
| EP-3466917-A1 | METHOD FOR PREPARING (7E)- 7,9-DECADIENOATE ESTER | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-04-10 | — | — | EP | disclosed |
| US-20180104257-A1 | (17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use | LIPOCINE INC. (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180078568-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2018-03-22 | — | — | US | disclosed |
| EP-3185873-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | Lipocine Inc. (US) | 2017-07-05 | — | — | EP | disclosed |
| US-20160193225-A1 | (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160184324-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-06-30 | — | — | US | disclosed |
| WO-2016033611-A1 | (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| WO-2016033536-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190106374-A1 | METHOD FOR PREPARING (7E)-7, 9-DECADIENOATE ESTER | DHCR7, DECR1, CYP7A1 | FASN 990/4885MAPT 4874/4885ABCC4 3955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.